Abstract:Objective To study the efficacy of the combination of 10μg yeast-recombinated hepatitis B vaccine (HepB) and hepatitis B immunoglobulin (HBIG) administrated to infants born to hepatitis B surface antigen (HBsAg)-positive mothers.Methods Investigation on blocking HBV mother-to-child transmission of children born to HBsAg-positive mothers with a combination of HBIG and 10μg HepB was conducted in Haidian District,Beijing,2013-2015.Data,including demographic information,the status of mother's hepatitis B e antigen (HBeAg) before delivery,and information of vaccination,such as the time of HBIG and of HepB,the type of hospital of birth,the dosage of HBIG,et al,were collected through questionnaires.5 ml blood samples of the children's were collected and then separated into the serum.Serological samples were tested for antibody to HBsAg (anti-HBs),HBsAg,and antibody to hepatitis B core antigen (anti-HBc).The positive rates of HBsAg,anti-HBc and anti-HBs were calculated and compared for different children.Results A total of 377 children born to HBsAg-positive mothers were included.Of these children,344 (91.25％) was positive for anti-HBs,33 (8.75％) was negative for antiHBs.The univariate analysis showed the positive rate of anti-HBs was significantly different for the children with the intervals between the time of administration of HepB3 and blood samples collected (x2 for corrected =30.432,P ＜ 0.001).The multiple logistic analysis showed children administrated different doses of HBIG (P =0.018) and with the intervals between the time of administration of HepB3 and blood samples collected (P ＜ 0.001) were significantly associated the anti-HBs positive or not.Compared with the children administrated 100IU HBIG,the children administrated 200IU HBIG were significantly less likely positive for anti-H Bs (OR =0.352,95 ％ CI:0.148 ～ 0.834).And compared with the children with the intervals between the time of blood sampled and administration of HepB3 ＜ 3 years,children with the intervals ≥ 3 years were significantly less likely positive for anti-HBs (OR =0.119,95％ CI:0.054 ～ 0.262).Conclusion Combination of HBIG and 10 μg HepB can effectively block mother-to-child transmission of HBV for children born to HBsAg-positive mothers.The levels of antiHBs declined over time,particularly 3 years after the administration of HepB3.Postvaccination serologic testing for infants born to HBsAg-positive mothers,especially for both HBsAg-and HBeAg-positive mothers,is important to determine the status of the infants for HBV biomarker,and for the HepB booster.

Effect of neonatal immunoprophylaxis in mother-to-fetus transmission of HBV and analysis on risk factors for transmission

Application of hepatitis B immunoglobulin in prevention of mother-to-child transmission of chronic hepatitis B in HBsAg- and HBeAg-positive mother

Evaluation for Effects of Routine Administration of Hepatitis B Vaccine and Hepatitis B Immunoglobulin on Preventing Mother-to-Infant Transmission of HBV-infected Mothers with Negative HBeAg

Effect of Prophylactic Antiviral Intervention on T Cell Immunity in Hepatitis B Virus-Infected Pregnant Women

Protective effect of regular immunoprophylaxis on infants against perinatal hepatitis B virus infection

Further Improving the Efficacy of HBV Vaccination in the Prevention of Mother-to-infant Transmission of Hepatitis B

The efficacy of immune interruptions on blocking mother-toinfant transmission of hepatitis B virus

Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates

The effect of antepartum injection of hepatitis B immunoglobulin on blocking the mother-to-infant transmission of HBV

Immune Response to Hepatitis B Vaccine in Children Born to HBsAg Positive Mothers: a Meta-Regression Analysis

Study interrelated of Hepatitis B Virus Transmission from Mothers to Infants with HBV-DNA quantitive PCR

Influence of Feeding Modes on Risk of Mother-to-child Transmission of Hepatitis B Virus

Real-world Efficacy of Immunoprophylaxis Against Mother-to-infant Transmission of Hepatitis B Virus Based on Puerperant Population

Efficacy and related factors of hepatitis B immunoglobulin and hepatitis B vaccination in blocking mother-to-child transmission of HBV among 377 children

Increased Protection of Earlier Use of Immunoprophylaxis in Preventing Perinatal Transmission of Hepatitis B Virus.

Effects of different feeding patterns on mother-to-child transmission of HBV infections in pregnant women with high viral loads after antiviral medication during pregnancy: A prospective cohort study

Follow-up Study on Efficacy of Blocking Mother-to-infant Transmission of HBV and Its Influence Factors in Jiangsu Province, 2010-2015

The Efficacy of Two Different Dosages of Hepatitis B Immunoglobulin Combined with Hepatitis B Vaccine in Preventing Mother-to-child Transmission of Hepatitis B Virus: A Prospective Cohort Study

Epidemiological trends and virological traits of hepatitis B virus infection in pregnant women and neonates

STUDY ON THE RELATIONSHIP BETWEEN HBV REPLACATION OF GRAVIDA AND THEIR NEWBORN INFECTION

The impact of antepartum injection of hepatitis B immunoglobulin on maternal serum HBV DNA and anti-HBs in the newborns]